Magellan is a private Australian company with expertise in research, development and manufacturing of stem cells for the treatment of osteoarthritis. We lead the way globally in scientific, clinical and commercial expertise for stem cell supply and development, for autologous treatments (using the patient’s own cells), and allogeneic treatments (using selected donor cells). We have more than 10 years of commercial stem-cell manufacturing expertise and have cultured more than 300 billion stem cells during this time.
| Website | http://magellanstemcells.com.au |
| Employees | 17 (11 on RocketReach) |
| Founded | 2012 |
| Address | 116-118 Thames Street, Suite 2.08, Box Hill North, Victoria 3129, AU |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Research |
| Keywords | Stem Cell Therapy, Stem Cell Treatment, Osteoarthritis Treatment, Regenerative Medicine, Cell Therapy, Stem Cell Research, Joint Pain Relief, Cartilage Repair, Tissue Regeneration, Clinical Trials, Biological Therapies, Advanced Therapies, Medical Research, Drug Development, Biotechnology, Pharmaceutical, Healthcare |
| Competitors | Organogenesis, Mesoblast Limited, Athersys, Regenative Labs, International Society For Cellular Therapy, Cynata Therapeutics, CBMG Holdings, TiGenix, CureMeta LLC, Stem Cells Australia +32 more (view full list) |
Looking for a particular Magellan Stem Cells employee's phone or email?
Julien Freitag is the CEO of Magellan Stem Cells.
11 people are employed at Magellan Stem Cells.
Magellan Stem Cells is based in Box Hill North, Victoria.